Contrasting effects of ascorbate and iron on the pulmonary vascular response to hypoxia in humans

Physiological Reports

Volumn 2, Issue 12, 2014, Pages

  Talbot, Nick P ^a   Croft, Quentin P ^a   Kate Curtis, M ^a   Turner, Brandon E ^a   Dorrington, Keith L ^a   Robbins, Peter A ^a   Smith, Thomas G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Ascorbate; Hypoxia inducible factor; Hypoxic pulmonary vasoconstriction; Iron; Pulmonary circulation; Vitamin C

Indexed keywords

ASCORBIC ACID; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR; IRON; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDROXYLATION; HYPOXIA; LUNG ARTERY PRESSURE; LUNG VASOCONSTRICTION; MALE; NORMAL HUMAN; OXYGEN SATURATION; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 85003598105     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12220     Document Type: Article

References (54)

1. Allemann, Y., C. Sartori, M. Lepori, S. Pierre, C. Melot, R. Naeije, et al. 2000. Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am. J. Physiol. Heart Circ. Physiol. 279: H2013-H2016.
2. Balanos, G. M., N. P. Talbot, P. A. Robbins, and K. L. Dorrington. 2005. Separating the direct effect of hypoxia from the indirect effect of changes in cardiac output on the maximum pressure difference across the tricuspid valve in healthy humans. Pflügers Arch. Eur. J. Physiol. 450:372-380.
3. Ball, M. K., G. B. Waypa, P. T. Mungai, J. M. Nielsen, L. Czech, V. J. Dudley, et al. 2014. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1α. Am. J. Respir. Crit. Care Med. 189:314-324.
4. Barbera, J. A., V. I. Peinado, and S. Santos. 2003. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur. Respir. J. 21:892-905.
5. Bond, J., D. P. Gale, T. Connor, S. Adams, J. de Boer, D. M. Gascoyne, et al. 2011. Dysregulation of the HIF pathway due to VHL mutation causing severe erythrocytosis and pulmonary arterial hypertension. Blood 117:3699-3701.
6. Brusselmans, K., V. Compernolle, M. Tjwa, M. S. Wiesener, P. H. Maxwell, D. Collen, et al. 2003. Heterozygous deficiency of hypoxia-inducible factor-2a protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J. Clin. Invest. 111:1519-1527.
7. Bushuev, V. I., G. Y. Miasnikova, A. I. Sergueeva, L. A. Polyakova, D. Okhotin, P. R. Gaskin, et al. 2006. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica 91:744-749.
8. Duvall, M. G., Y. Pikman, D. B. Kantor, K. Ariagno, L. Summers, T. C. Sectish, et al. 2013. Pulmonary hypertension associated with scurvy and vitamin deficiencies in an autistic child. Pediatrics 132:e1699-e1703.
9. Epstein, A., J. Gleadle, L. McNeill, K. Hewitson, J. O’Rourke, D. Mole, et al. 2001. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
10. Flashman, E., S. L. Davies, K. K. Yeoh, and C. J. Schofield. 2010. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents. Biochem. J. 427:135-142.
11. Formenti, F., P. A. Beer, Q. P. Croft, K. L. Dorrington, D. P. Gale, T. R. Lappin, et al. 2011. Cardiopulmonary function in two human disorders of the hypoxia-inducible factor (HIF) pathway: von Hippel-Lindau disease and HIF-2a gain-of-function mutation. FASEB J. 25:2001-2011.
12. Gale, D. P., S. K. Harten, C. D. Reid, E. G. Tuddenham, and P. H. Maxwell. 2008. Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2a mutation. Blood 112:919-921.
13. Ghosh, M. C., D. L. Zhang, S. Y. Jeong, G. Kovtunovych, H. Ollivierre-Wilson, A. Noguchi, et al. 2013. Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2a. Cell Metab. 17:271-281.
14. Hickey, M. M., T. Richardson, T. Wang, M. Mosqueira, E. Arguiri, H. Yu, et al. 2010. The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J. Clin. Invest. 120:827-839.
15. Hirsila, M., P. Koivunen, V. Gunzler, K. I. Kivirikko, and J. Myllyharju. 2003. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278:30772-30780.
16. Howard, L. S. G. E., R. A. Barson, B. P. A. Howse, T. R. McGill, M. E. McIntyre, D. F. O’Connor, et al. 1995. Chamber for controlling the end-tidal gas tensions over sustained periods in humans. J. Appl. Physiol. 78: 1088-1091.
17. Howard, L. S., G. M. Watson, J. Wharton, C. J. Rhodes, K. Chan, R. Khengar, et al. 2013. Supplementation of iron in pulmonary hypertension: rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension. Pulm. Circ. 3:100-107.
18. Ivan, M., K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, et al. 2001. HIFa targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464-468.
19. Jaakkola, P., D. R. Mole, Y.-M. Tian, M. I. Wilson, J. Gielbert, S. J. Gaskell, et al. 2001. Targeting of HIF-a to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472.
20. Knowles, H. J., R. R. Raval, A. L. Harris, and P. J. Ratcliffe. 2003. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63:1764-1768.
21. Knowles, H. J., D. R. Mole, P. J. Ratcliffe, and A. L. Harris. 2006. Normoxic stabilization of hypoxia-inducible factor-1α by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res. 66:2600-2607.
22. Kuiper, C., G. U. Dachs, M. J. Currie, and M. C. Vissers. 2014. Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response. Free Radic. Biol. Med. 69:308-317.
23. Kupari, M., and J. Rapola. 2012. Reversible pulmonary hypertension associated with vitamin C deficiency. Chest 142:225-227.
24. Li, S. H., J. H. Ryu, S. E. Park, Y. S. Cho, J. W. Park, W. J. Lee, et al. 2010. Vitamin C supplementation prevents testosterone-induced hyperplasia of rat prostate by down-regulating HIF-1α. J. Nutr. Biochem. 21:801-808.
25. Manalo, D. J., A. Rowan, T. Lavoie, L. Natarajan, B. D. Kelly, S. Q. Ye, et al. 2005. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105:659-669.
26. Martinez-Bello, V. E., F. Sanchis-Gomar, D. Martinez-Bello, G. Olaso-Gonzalez, M. C. Gomez-Cabrera, and J. Vina. 2012. Vitamin C supplementation does not improve hypoxia-induced erythropoiesis. High Alt. Med. Biol. 13:269-274.
27. Mehta, C. L., D. Cripps, and A. J. Bridges. 1996. Systemic pseudovasculitis from scurvy in anorexia nervosa. Arthritis Rheumatol. 39:532-533.
28. Mertens, M. T., and E. Gertner. 2011. Rheumatic manifestations of scurvy: a report of three recent cases in a major urban center and a review. Semin. Arthritis Rheum. 41:286-290.
29. Muhlhofer, A., S. Mrosek, B. Schlegel, W. Trommer, F. Rozario, H. Bohles, et al. 2004. High-dose intravenous vitamin C is not associated with an increase of pro-oxidative biomarkers. Eur. J. Clin. Nutr. 58:1151-1158.
30. Nagamatsu, S., A. Nahum, and C. E. McEvoy. 2009. Pulmonary hypertension secondary to vitamin C deficiency. Chest 136:4S.
31. Nytko, K. J., N. Maeda, P. Schlafli, P. Spielmann, R. H. Wenger, and D. P. Stiehl. 2011. Vitamin C is dispensable for oxygen sensing in vivo. Blood 117:5485-5493.
32. Padayatty, S. J., H. Sun, Y. Wang, H. D. Riordan, S. M. Hewitt, A. Katz, et al. 2004. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med. 140:533-537.
33. Rhodes, C. J., J. Wharton, L. Howard, J. S. Gibbs, A. Vonk-Noordegraaf, and M. R. Wilkins. 2011. Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target. Eur. Respir. J. 38:1453-1460.
34. Semenza, G. L. 2009. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 24: 97-106.
35. Shimoda, L. A., and S. S. Laurie. 2014. HIF and pulmonary vascular responses to hypoxia. J. Appl. Physiol. 116:867-874.
36. Shimoda, L. A., D. J. Manalo, J. S. K. Sham, G. L. Semenza, and J. T. Sylvester. 2001. Partial HIF-1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L202-L208.
37. Shimoda, L. A., M. Fallon, S. Pisarcik, J. Wang, and G. L. Semenza. 2006. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am. J. Physiol. Lung Cell. Mol. Physiol. 291:L941-L949.
38. Smith, T. G., and N. P. Talbot. 2010. Prolyl hydroxylases and therapeutics. Antioxid. Redox Signal. 12:431-433.
39. Smith, T. G., J. T. Brooks, G. M. Balanos, T. R. Lappin, D. M. Layton, D. L. Leedham, et al. 2006. Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med. 3:e290.
40. Smith, T. G., G. M. Balanos, Q. P. Croft, N. P. Talbot, K. L. Dorrington, P. J. Ratcliffe, et al. 2008a. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J. Physiol. 586(Pt 24):5999-6005.
41. Smith, T. G., P. A. Robbins, and P. J. Ratcliffe. 2008b. The human side of hypoxia-inducible factor. Br. J. Haematol. 141:325-334.
42. Smith, T. G., J. T. Brooks, G. M. Balanos, T. R. Lappin, D. M. Layton, D. L. Leedham, et al. 2008c. Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology. Adv. Exp. Med. Biol. 605:51-56.
43. Smith, T. G., N. P. Talbot, C. Privat, M. Rivera-Ch, A. H. Nickol, P. J. Ratcliffe, et al. 2009. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. J. Am. Med. Assoc. 302:1444-1450.
44. Smith, T. G., N. P. Talbot, R. W. Chang, E. Wilkinson, A. H. Nickol, D. G. Newman, et al. 2012. Pulmonary artery pressure increases during commercial air travel in healthy passengers. Aviat. Space Environ. Med. 83:673-676.
45. Smith, T. G., R. W. Chang, P. A. Robbins, and K. L. Dorrington. 2013. Commercial air travel and in-flight pulmonary hypertension. Aviat. Space Environ. Med. 84: 65-67.
46. Talbot, N. P., G. M. Balanos, K. L. Dorrington, and P. A. Robbins. 2005. Two temporal components within the human pulmonary vascular response to ~2 h of isocapnic hypoxia. J. Appl. Physiol. 98:1125-1139.
47. Tan, Q., H. Kerestes, M. J. Percy, R. Pietrofesa, L. Chen, T. S. Khurana, et al. 2013. Erythrocytosis and pulmonary hypertension in a mouse model of human HIF2A gain of function mutation. J. Biol. Chem. 288:17134-17144.
48. Vissers, M. C., and R. P. Wilkie. 2007. Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1α. J. Leukoc. Biol. 81:1236-1244.
49. Vissers, M. C., S. P. Gunningham, M. J. Morrison, G. U. Dachs, and M. J. Currie. 2007. Modulation of hypoxia-inducible factor-1α in cultured primary cells by intracellular ascorbate. Free Radic. Biol. Med. 42:765-772.
50. Wang, G. L., and G. L. Semenza. 1993. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615.
51. Wang, J., L. Weigand, W. Lu, J. T. Sylvester, G. L. Semenza, and L. A. Shimoda. 2006. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells. Circ. Res. 98:1528-1537.
52. Yock, P. G., and R. L. Popp. 1984. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70:657-662.
53. Yu, A. Y., L. A. Shimoda, N. V. Iyer, D. L. Huso, X. Sun, R. McWilliams, et al. 1999. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J. Clin. Invest. 103:691-696.
54. Yu, F., S. B. White, Q. Zhao, and F. S. Lee. 2001. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. U.S.A. 98:9630-9635.